|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taby R and Issa JP: Cancer epigenetics. CA
Cancer J Clin. 60:376–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoque MO, Prencipe M, Poeta ML, Barbano R,
Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, et
al: Changes in CpG islands promoter methylation patterns during
ductal breast carcinoma progression. Cancer Epidemiol Biomarkers
Prev. 18:2694–2700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiang TX, Yuan Y, Li LL, Wang ZH, Dan LY,
Chen Y, Ren GS and Tao Q: Aberrant promoter CpG methylation and its
translational applications in breast cancer. Chin J Cancer.
32:12–20. 2013. View Article : Google Scholar :
|
|
7
|
Revet I, Huizenga G, Koster J, Volckmann
R, van Sluis P, Versteeg R and Geerts D: MSX1 induces the Wnt
pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in
neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling
to DVL3. Cancer Lett. 289:195–207. 2010. View Article : Google Scholar
|
|
8
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar
|
|
10
|
McGinnis W and Krumlauf R: Homeobox genes
and axial patterning. Cell. 68:283–302. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sliwinski T, Synowiec E, Czarny P, Gomulak
P, Forma E, Morawiec Z, Morawiec J, Dziki L, Wasylecka M and
Blasiak J: The c.469+46_56del mutation in the homeobox MSX1 gene -
a novel risk factor in breast cancer? Cancer Epidemiol. 34:652–655.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saadi I, Das P, Zhao M, Raj L, Ruspita I,
Xia Y, Papaioannou VE and Bei M: Msx1 and Tbx2 antagonistically
regulate Bmp4 expression during the bud-to-cap stage transition in
tooth development. Development. 140:2697–2702. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nassif A, Senussi I, Meary F, Loiodice S,
Hotton D, Robert B, Bensidhoum M, Berdal A and Babajko S: Msx1 role
in craniofacial bone morphogenesis. Bone. 66:96–104. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bendall AJ and Abate-Shen C: Roles for Msx
and Dlx homeoproteins in vertebrate development. Gene. 247:17–31.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakatomi M, Wang XP, Key D, Lund JJ,
Turbe-Doan A, Kist R, Aw A, Chen Y, Maas RL and Peters H: Genetic
interactions between Pax9 and Msx1 regulate lip development and
several stages of tooth morphogenesis. Dev Biol. 340:438–449. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ceyhan D, Kirzioglu Z and Calapoglu NS:
Mutations in the MSX1 gene in Turkish children with non-syndromic
tooth agenesis and other dental anomalies. Indian J Dent.
5:172–182. 2014. View Article : Google Scholar :
|
|
17
|
Dunwell TL, Hesson LB, Pavlova T,
Zabarovska V, Kashuba V, Catchpoole D, Chiaramonte R, Brini AT,
Griffiths M, Maher ER, et al: Epigenetic analysis of childhood
acute lymphoblastic leukemia. Epigenetics. 4:185–193. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park K, Kim K, Rho SB, Choi K, Kim D, Oh
SH, Park J, Lee SH and Lee JH: Homeobox Msx1 interacts with p53
tumor suppressor and inhibits tumor growth by inducing apoptosis.
Cancer Res. 65:749–757. 2005.PubMed/NCBI
|
|
19
|
Yamashita S, Tsujino Y, Moriguchi K,
Tatematsu M and Ushijima T: Chemical genomic screening for
methylation-silenced genes in gastric cancer cell lines using
5-aza-2′-deoxycytidine treatment and oligonucleotide microarray.
Cancer Sci. 97:64–71. 2006. View Article : Google Scholar
|
|
20
|
Bonds J, Pollan-White S, Xiang L, Mues G
and D' Souza R: Is there a link between ovarian cancer and tooth
agenesis? Eur J Med Genet. 57:235–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baylin SB and Ohm JE: Epigenetic gene
silencing in cancer - a mechanism for early oncogenic pathway
addiction? Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park J, Park K, Kim S and Lee JH: Msx1
gene overexpression induces G1 phase cell arrest in human ovarian
cancer cell line OVCAR3. Biochem Biophys Res Commun. 281:1234–1240.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ringner M, Fredlund E, Hakkinen J, Borg A
and Staaf J: GOBO: gene expression-based outcome for breast cancer
online. PLoS One. 6:e179112011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang T, Li L, Yin X, Yuan C, Tan C, Su X,
Xiong L, Putti TC, Oberst M, Kelly K, et al: The ubiquitin
peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis
through stabilizing p53 and is frequently silenced in breast
cancer. PLoS One. 7:e297832012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giusti AF, O' Neill FJ, Yamasu K, Foltz KR
and Jaffe LA: Function of a sea urchin egg Src family kinase in
initiating Ca2+ release at fertilization. Dev Biol.
256:367–378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Chesi M and Bergsagel PL: Epigenetics and
microRNAs combine to modulate the MDM2/p53 axis in myeloma. Cancer
Cell. 18:299–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Veeman MT, Axelrod JD and Moon RT: A
second canon. Functions and mechanisms of beta-catenin-independent
Wnt signaling. Dev Cell. 5:367–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seidensticker MJ and Behrens J:
Biochemical interactions in the wnt pathway. Biochim Biophys Acta.
1495:168–182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tao H, Guo L, Chen L, Qiao G, Meng X, Xu B
and Ye W: MSX1 inhibits cell migration and invasion through
regulating the Wnt/β-catenin pathway in glioblastoma. Tumour Biol.
37:1097–1104. 2016. View Article : Google Scholar
|
|
34
|
Hu Z, Fan C, Oh DS, Marron JS, He X,
Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, et al: The
molecular portraits of breast tumors are conserved across
microarray platforms. BMC Genomics. 7:962006. View Article : Google Scholar : PubMed/NCBI
|
